Capacity Assessment in Persons With Alzheimer's Disease (MACAP)
The purpose of this study is to assess decision-making capacity in persons with Alzheimer's disease. First, our goal is to validate four French capacity assessment tools for persons with Alzheimer's Disease : a French version of the Competency Assessment Tool for Consent to Treatment and of the Competency Assessment Tool for Voting, two questionnaires assessing the capacity to appoint a proxy either to consent to treatment or to vote. Second, once validated, we plan these questionnaires to study decision-making abilities and their determinants in persons with Alzheimer's disease and control subjects.
Capacity to Consent to Treatment
Capacity to Vote
Capacity to Design a Proxy
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Prospective
|Official Title:||Decision Capacity Assessment in Persons With Alzheimer's Disease: Approach by Capacity to Appoint a Proxy, to Consent to Treatment and to Vote|
|Study Start Date:||June 2010|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Study of Alzheimer's disease patients show a wide variability in decision-making abilities, especially for the consent to treatment and the ability to vote. No tools are available to assess the capacity to design a proxy. The purpose of this research is to assess simultaneously four decision-making abilities in persons with Alzheimer's disease: the capacity to consent to treatment, the capacity to vote and the capacity to design a proxy either to consent to treatment or to vote.
This study will recruit 320 patients with Alzheimer's disease and 80 non-demented control subjects. Four decision-making questionnaires will be administered to participants to explore participant capacity to understand, reason, appreciate and make a choice about the capacity to consent to treatment, to vote and to design a proxy either to consent to treatment or to vote. Once validated in the first part of this research, the questionnaires will be used to study decision-making abilities and their determinants in patients with Alzheimer's disease and control subjects.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01190800
|Contact: Antoine Bosquet, MD||+33(0) 1 47 60 65 email@example.com|
|Hôpital Louis Mourier||Recruiting|
|Colombes, France, 92700|
|Contact: Antoine Bosquet, MD +33(0) 1 47 60 65 48 firstname.lastname@example.org|
|Contact: Laurence Salomon, MD +33(0) 1 47 60 67 27 email@example.com|
|Principal Investigator:||Antoine Bosquet, MD||Assistance Publique - Hôpitaux de Paris|